Ductal carcinoma in situ (DCIS) can be a predictor for invasive breast cancer if untreated, and is seen in around 45 percent of patients with invasive ductal carcinoma (IDC). Patients who only have DCIS, have a 5-year-survival of almost 100 percent on contrast to 89 percent of all stages of invasive breast cancer...
More...